nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—SLCO2B1—Conjugated Estrogens—osteoporosis	0.129	0.162	CbGbCtD
Fexofenadine—SLCO1B3—Conjugated Estrogens—osteoporosis	0.114	0.144	CbGbCtD
Fexofenadine—SLCO2B1—Estradiol—osteoporosis	0.113	0.142	CbGbCtD
Fexofenadine—SLCO1B3—Estradiol—osteoporosis	0.1	0.126	CbGbCtD
Fexofenadine—SLCO1A2—Conjugated Estrogens—osteoporosis	0.0705	0.0887	CbGbCtD
Fexofenadine—SLCO1B1—Conjugated Estrogens—osteoporosis	0.0665	0.0837	CbGbCtD
Fexofenadine—SLCO1A2—Estradiol—osteoporosis	0.0619	0.0779	CbGbCtD
Fexofenadine—SLCO1B1—Estradiol—osteoporosis	0.0584	0.0735	CbGbCtD
Fexofenadine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0259	0.0327	CbGbCtD
Fexofenadine—CYP2D6—Cholecalciferol—osteoporosis	0.0195	0.0246	CbGbCtD
Fexofenadine—ABCB1—Conjugated Estrogens—osteoporosis	0.019	0.024	CbGbCtD
Fexofenadine—ABCB1—Estradiol—osteoporosis	0.0167	0.0211	CbGbCtD
Fexofenadine—Loperamide—POMC—osteoporosis	0.00153	0.822	CrCbGaD
Fexofenadine—Hypersensitivity—Etidronic acid—osteoporosis	0.000464	0.00238	CcSEcCtD
Fexofenadine—Insomnia—Calcitriol—osteoporosis	0.000462	0.00238	CcSEcCtD
Fexofenadine—Agitation—Pamidronate—osteoporosis	0.000461	0.00237	CcSEcCtD
Fexofenadine—Cough—Risedronate—osteoporosis	0.00046	0.00237	CcSEcCtD
Fexofenadine—Dyspepsia—Ibandronate—osteoporosis	0.00046	0.00236	CcSEcCtD
Fexofenadine—Pain—Alendronate—osteoporosis	0.000459	0.00236	CcSEcCtD
Fexofenadine—Angioedema—Pamidronate—osteoporosis	0.000458	0.00235	CcSEcCtD
Fexofenadine—Somnolence—Calcitriol—osteoporosis	0.000454	0.00234	CcSEcCtD
Fexofenadine—Pain—Raloxifene—osteoporosis	0.000451	0.00232	CcSEcCtD
Fexofenadine—Fatigue—Ibandronate—osteoporosis	0.00045	0.00231	CcSEcCtD
Fexofenadine—Myalgia—Risedronate—osteoporosis	0.000449	0.00231	CcSEcCtD
Fexofenadine—Pain—Ibandronate—osteoporosis	0.000447	0.0023	CcSEcCtD
Fexofenadine—Pruritus—Etidronic acid—osteoporosis	0.000445	0.00229	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Estropipate—osteoporosis	0.000445	0.00229	CcSEcCtD
Fexofenadine—Back pain—Zoledronate—osteoporosis	0.000443	0.00228	CcSEcCtD
Fexofenadine—Dry mouth—Risedronate—osteoporosis	0.000439	0.00226	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Alendronate—osteoporosis	0.000439	0.00225	CcSEcCtD
Fexofenadine—Infection—Ethinyl Estradiol—osteoporosis	0.000439	0.00225	CcSEcCtD
Fexofenadine—Cough—Pamidronate—osteoporosis	0.000437	0.00225	CcSEcCtD
Fexofenadine—Pain—Calcitriol—osteoporosis	0.000437	0.00225	CcSEcCtD
Fexofenadine—Flatulence—Conjugated Estrogens—osteoporosis	0.000434	0.00223	CcSEcCtD
Fexofenadine—Tension—Conjugated Estrogens—osteoporosis	0.000433	0.00222	CcSEcCtD
Fexofenadine—Urticaria—Estropipate—osteoporosis	0.000433	0.00222	CcSEcCtD
Fexofenadine—Vision blurred—Zoledronate—osteoporosis	0.000432	0.00222	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Raloxifene—osteoporosis	0.000431	0.00222	CcSEcCtD
Fexofenadine—Diarrhoea—Etidronic acid—osteoporosis	0.000431	0.00221	CcSEcCtD
Fexofenadine—Abdominal pain—Estropipate—osteoporosis	0.000431	0.00221	CcSEcCtD
Fexofenadine—Body temperature increased—Estropipate—osteoporosis	0.000431	0.00221	CcSEcCtD
Fexofenadine—Nervousness—Conjugated Estrogens—osteoporosis	0.000428	0.0022	CcSEcCtD
Fexofenadine—Infection—Risedronate—osteoporosis	0.000428	0.0022	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Ibandronate—osteoporosis	0.000427	0.00219	CcSEcCtD
Fexofenadine—Myalgia—Pamidronate—osteoporosis	0.000427	0.00219	CcSEcCtD
Fexofenadine—Back pain—Conjugated Estrogens—osteoporosis	0.000427	0.00219	CcSEcCtD
Fexofenadine—Urticaria—Alendronate—osteoporosis	0.000426	0.00219	CcSEcCtD
Fexofenadine—Epistaxis—Estradiol—osteoporosis	0.000426	0.00219	CcSEcCtD
Fexofenadine—Abdominal pain—Alendronate—osteoporosis	0.000424	0.00218	CcSEcCtD
Fexofenadine—Body temperature increased—Alendronate—osteoporosis	0.000424	0.00218	CcSEcCtD
Fexofenadine—Sinusitis—Estradiol—osteoporosis	0.000424	0.00218	CcSEcCtD
Fexofenadine—Agitation—Zoledronate—osteoporosis	0.000421	0.00216	CcSEcCtD
Fexofenadine—Angioedema—Zoledronate—osteoporosis	0.000418	0.00215	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000418	0.00215	CcSEcCtD
Fexofenadine—Abdominal pain—Raloxifene—osteoporosis	0.000417	0.00214	CcSEcCtD
Fexofenadine—Body temperature increased—Raloxifene—osteoporosis	0.000417	0.00214	CcSEcCtD
Fexofenadine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000416	0.00214	CcSEcCtD
Fexofenadine—Urticaria—Ibandronate—osteoporosis	0.000415	0.00213	CcSEcCtD
Fexofenadine—Abdominal pain—Ibandronate—osteoporosis	0.000413	0.00212	CcSEcCtD
Fexofenadine—Body temperature increased—Ibandronate—osteoporosis	0.000413	0.00212	CcSEcCtD
Fexofenadine—Anaphylactic shock—Pamidronate—osteoporosis	0.000409	0.0021	CcSEcCtD
Fexofenadine—Infection—Pamidronate—osteoporosis	0.000406	0.00209	CcSEcCtD
Fexofenadine—Urticaria—Calcitriol—osteoporosis	0.000406	0.00209	CcSEcCtD
Fexofenadine—Palpitations—Zoledronate—osteoporosis	0.000405	0.00208	CcSEcCtD
Fexofenadine—Abdominal pain—Calcitriol—osteoporosis	0.000404	0.00208	CcSEcCtD
Fexofenadine—Body temperature increased—Calcitriol—osteoporosis	0.000404	0.00208	CcSEcCtD
Fexofenadine—Angioedema—Conjugated Estrogens—osteoporosis	0.000403	0.00207	CcSEcCtD
Fexofenadine—Hypersensitivity—Estropipate—osteoporosis	0.000401	0.00206	CcSEcCtD
Fexofenadine—Vomiting—Etidronic acid—osteoporosis	0.0004	0.00206	CcSEcCtD
Fexofenadine—Cough—Zoledronate—osteoporosis	0.0004	0.00205	CcSEcCtD
Fexofenadine—Tachycardia—Pamidronate—osteoporosis	0.000399	0.00205	CcSEcCtD
Fexofenadine—Rash—Etidronic acid—osteoporosis	0.000397	0.00204	CcSEcCtD
Fexofenadine—Dermatitis—Etidronic acid—osteoporosis	0.000397	0.00204	CcSEcCtD
Fexofenadine—Hypersensitivity—Alendronate—osteoporosis	0.000395	0.00203	CcSEcCtD
Fexofenadine—Headache—Etidronic acid—osteoporosis	0.000394	0.00203	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000392	0.00202	CcSEcCtD
Fexofenadine—Asthenia—Estropipate—osteoporosis	0.000391	0.00201	CcSEcCtD
Fexofenadine—Myalgia—Zoledronate—osteoporosis	0.00039	0.002	CcSEcCtD
Fexofenadine—Palpitations—Conjugated Estrogens—osteoporosis	0.00039	0.002	CcSEcCtD
Fexofenadine—Insomnia—Risedronate—osteoporosis	0.000389	0.002	CcSEcCtD
Fexofenadine—Pruritus—Estropipate—osteoporosis	0.000385	0.00198	CcSEcCtD
Fexofenadine—Asthenia—Alendronate—osteoporosis	0.000385	0.00198	CcSEcCtD
Fexofenadine—Hypersensitivity—Ibandronate—osteoporosis	0.000385	0.00198	CcSEcCtD
Fexofenadine—Cough—Conjugated Estrogens—osteoporosis	0.000385	0.00198	CcSEcCtD
Fexofenadine—Dyspnoea—Risedronate—osteoporosis	0.000384	0.00197	CcSEcCtD
Fexofenadine—Dry mouth—Zoledronate—osteoporosis	0.000381	0.00196	CcSEcCtD
Fexofenadine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000381	0.00196	CcSEcCtD
Fexofenadine—Pruritus—Alendronate—osteoporosis	0.00038	0.00195	CcSEcCtD
Fexofenadine—Dyspepsia—Risedronate—osteoporosis	0.000379	0.00195	CcSEcCtD
Fexofenadine—Hypersensitivity—Calcitriol—osteoporosis	0.000377	0.00194	CcSEcCtD
Fexofenadine—Flushing—Estradiol—osteoporosis	0.000376	0.00193	CcSEcCtD
Fexofenadine—Myalgia—Conjugated Estrogens—osteoporosis	0.000375	0.00193	CcSEcCtD
Fexofenadine—Asthenia—Ibandronate—osteoporosis	0.000375	0.00193	CcSEcCtD
Fexofenadine—Nausea—Etidronic acid—osteoporosis	0.000374	0.00192	CcSEcCtD
Fexofenadine—Anaphylactic shock—Zoledronate—osteoporosis	0.000374	0.00192	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000373	0.00192	CcSEcCtD
Fexofenadine—Diarrhoea—Estropipate—osteoporosis	0.000373	0.00192	CcSEcCtD
Fexofenadine—Infection—Zoledronate—osteoporosis	0.000371	0.00191	CcSEcCtD
Fexofenadine—Fatigue—Risedronate—osteoporosis	0.000371	0.00191	CcSEcCtD
Fexofenadine—Insomnia—Pamidronate—osteoporosis	0.00037	0.0019	CcSEcCtD
Fexofenadine—Pruritus—Ibandronate—osteoporosis	0.000369	0.0019	CcSEcCtD
Fexofenadine—Pain—Risedronate—osteoporosis	0.000368	0.00189	CcSEcCtD
Fexofenadine—Diarrhoea—Alendronate—osteoporosis	0.000367	0.00189	CcSEcCtD
Fexofenadine—Asthenia—Calcitriol—osteoporosis	0.000367	0.00189	CcSEcCtD
Fexofenadine—Dyspnoea—Pamidronate—osteoporosis	0.000365	0.00187	CcSEcCtD
Fexofenadine—Tachycardia—Zoledronate—osteoporosis	0.000365	0.00187	CcSEcCtD
Fexofenadine—Somnolence—Pamidronate—osteoporosis	0.000364	0.00187	CcSEcCtD
Fexofenadine—Pruritus—Calcitriol—osteoporosis	0.000362	0.00186	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000361	0.00186	CcSEcCtD
Fexofenadine—Diarrhoea—Raloxifene—osteoporosis	0.000361	0.00186	CcSEcCtD
Fexofenadine—Dyspepsia—Pamidronate—osteoporosis	0.00036	0.00185	CcSEcCtD
Fexofenadine—Dizziness—Estropipate—osteoporosis	0.00036	0.00185	CcSEcCtD
Fexofenadine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00036	0.00185	CcSEcCtD
Fexofenadine—Infection—Conjugated Estrogens—osteoporosis	0.000358	0.00184	CcSEcCtD
Fexofenadine—Diarrhoea—Ibandronate—osteoporosis	0.000357	0.00184	CcSEcCtD
Fexofenadine—Dizziness—Alendronate—osteoporosis	0.000355	0.00182	CcSEcCtD
Fexofenadine—Fatigue—Pamidronate—osteoporosis	0.000353	0.00181	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Risedronate—osteoporosis	0.000352	0.00181	CcSEcCtD
Fexofenadine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000351	0.00181	CcSEcCtD
Fexofenadine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000351	0.0018	CcSEcCtD
Fexofenadine—Pain—Pamidronate—osteoporosis	0.00035	0.0018	CcSEcCtD
Fexofenadine—Diarrhoea—Calcitriol—osteoporosis	0.00035	0.0018	CcSEcCtD
Fexofenadine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000349	0.00179	CcSEcCtD
Fexofenadine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000349	0.00179	CcSEcCtD
Fexofenadine—Dizziness—Raloxifene—osteoporosis	0.000349	0.00179	CcSEcCtD
Fexofenadine—Flatulence—Estradiol—osteoporosis	0.000348	0.00179	CcSEcCtD
Fexofenadine—Tension—Estradiol—osteoporosis	0.000346	0.00178	CcSEcCtD
Fexofenadine—Vomiting—Estropipate—osteoporosis	0.000346	0.00178	CcSEcCtD
Fexofenadine—Dizziness—Ibandronate—osteoporosis	0.000345	0.00178	CcSEcCtD
Fexofenadine—Rash—Estropipate—osteoporosis	0.000343	0.00176	CcSEcCtD
Fexofenadine—Dermatitis—Estropipate—osteoporosis	0.000343	0.00176	CcSEcCtD
Fexofenadine—Nervousness—Estradiol—osteoporosis	0.000343	0.00176	CcSEcCtD
Fexofenadine—Urticaria—Risedronate—osteoporosis	0.000342	0.00176	CcSEcCtD
Fexofenadine—Back pain—Estradiol—osteoporosis	0.000341	0.00175	CcSEcCtD
Fexofenadine—Headache—Estropipate—osteoporosis	0.000341	0.00175	CcSEcCtD
Fexofenadine—Vomiting—Alendronate—osteoporosis	0.000341	0.00175	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00034	0.00175	CcSEcCtD
Fexofenadine—Abdominal pain—Risedronate—osteoporosis	0.00034	0.00175	CcSEcCtD
Fexofenadine—Body temperature increased—Risedronate—osteoporosis	0.00034	0.00175	CcSEcCtD
Fexofenadine—Rash—Alendronate—osteoporosis	0.000338	0.00174	CcSEcCtD
Fexofenadine—Insomnia—Zoledronate—osteoporosis	0.000338	0.00174	CcSEcCtD
Fexofenadine—Dermatitis—Alendronate—osteoporosis	0.000338	0.00174	CcSEcCtD
Fexofenadine—Headache—Alendronate—osteoporosis	0.000336	0.00173	CcSEcCtD
Fexofenadine—Vomiting—Raloxifene—osteoporosis	0.000335	0.00172	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000335	0.00172	CcSEcCtD
Fexofenadine—Dyspnoea—Zoledronate—osteoporosis	0.000333	0.00171	CcSEcCtD
Fexofenadine—Rash—Raloxifene—osteoporosis	0.000333	0.00171	CcSEcCtD
Fexofenadine—Dermatitis—Raloxifene—osteoporosis	0.000332	0.00171	CcSEcCtD
Fexofenadine—Somnolence—Zoledronate—osteoporosis	0.000332	0.00171	CcSEcCtD
Fexofenadine—Vomiting—Ibandronate—osteoporosis	0.000332	0.00171	CcSEcCtD
Fexofenadine—Methadone—CYP19A1—osteoporosis	0.000332	0.178	CrCbGaD
Fexofenadine—Headache—Raloxifene—osteoporosis	0.00033	0.0017	CcSEcCtD
Fexofenadine—Rash—Ibandronate—osteoporosis	0.000329	0.00169	CcSEcCtD
Fexofenadine—Dermatitis—Ibandronate—osteoporosis	0.000329	0.00169	CcSEcCtD
Fexofenadine—Dyspepsia—Zoledronate—osteoporosis	0.000329	0.00169	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000328	0.00169	CcSEcCtD
Fexofenadine—Headache—Ibandronate—osteoporosis	0.000327	0.00168	CcSEcCtD
Fexofenadine—Insomnia—Conjugated Estrogens—osteoporosis	0.000325	0.00167	CcSEcCtD
Fexofenadine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000325	0.00167	CcSEcCtD
Fexofenadine—Vomiting—Calcitriol—osteoporosis	0.000325	0.00167	CcSEcCtD
Fexofenadine—Agitation—Estradiol—osteoporosis	0.000324	0.00167	CcSEcCtD
Fexofenadine—Nausea—Estropipate—osteoporosis	0.000323	0.00166	CcSEcCtD
Fexofenadine—Body temperature increased—Pamidronate—osteoporosis	0.000323	0.00166	CcSEcCtD
Fexofenadine—Abdominal pain—Pamidronate—osteoporosis	0.000323	0.00166	CcSEcCtD
Fexofenadine—Angioedema—Estradiol—osteoporosis	0.000322	0.00166	CcSEcCtD
Fexofenadine—Rash—Calcitriol—osteoporosis	0.000322	0.00166	CcSEcCtD
Fexofenadine—Fatigue—Zoledronate—osteoporosis	0.000322	0.00166	CcSEcCtD
Fexofenadine—Dermatitis—Calcitriol—osteoporosis	0.000322	0.00166	CcSEcCtD
Fexofenadine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000321	0.00165	CcSEcCtD
Fexofenadine—Headache—Calcitriol—osteoporosis	0.00032	0.00165	CcSEcCtD
Fexofenadine—Somnolence—Conjugated Estrogens—osteoporosis	0.00032	0.00164	CcSEcCtD
Fexofenadine—Pain—Zoledronate—osteoporosis	0.00032	0.00164	CcSEcCtD
Fexofenadine—Nausea—Alendronate—osteoporosis	0.000319	0.00164	CcSEcCtD
Fexofenadine—Hypersensitivity—Risedronate—osteoporosis	0.000317	0.00163	CcSEcCtD
Fexofenadine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000317	0.00163	CcSEcCtD
Fexofenadine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000317	0.00163	CcSEcCtD
Fexofenadine—Nausea—Raloxifene—osteoporosis	0.000313	0.00161	CcSEcCtD
Fexofenadine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000312	0.00161	CcSEcCtD
Fexofenadine—Palpitations—Estradiol—osteoporosis	0.000312	0.0016	CcSEcCtD
Fexofenadine—Fatigue—Conjugated Estrogens—osteoporosis	0.00031	0.00159	CcSEcCtD
Fexofenadine—Nausea—Ibandronate—osteoporosis	0.00031	0.00159	CcSEcCtD
Fexofenadine—Asthenia—Risedronate—osteoporosis	0.000309	0.00159	CcSEcCtD
Fexofenadine—Cough—Estradiol—osteoporosis	0.000308	0.00158	CcSEcCtD
Fexofenadine—Pain—Conjugated Estrogens—osteoporosis	0.000308	0.00158	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000306	0.00157	CcSEcCtD
Fexofenadine—Pruritus—Risedronate—osteoporosis	0.000305	0.00157	CcSEcCtD
Fexofenadine—Nausea—Calcitriol—osteoporosis	0.000304	0.00156	CcSEcCtD
Fexofenadine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000302	0.00155	CcSEcCtD
Fexofenadine—Hypersensitivity—Pamidronate—osteoporosis	0.000301	0.00155	CcSEcCtD
Fexofenadine—Myalgia—Estradiol—osteoporosis	0.0003	0.00154	CcSEcCtD
Fexofenadine—Urticaria—Zoledronate—osteoporosis	0.000297	0.00153	CcSEcCtD
Fexofenadine—Body temperature increased—Zoledronate—osteoporosis	0.000295	0.00152	CcSEcCtD
Fexofenadine—Abdominal pain—Zoledronate—osteoporosis	0.000295	0.00152	CcSEcCtD
Fexofenadine—Diarrhoea—Risedronate—osteoporosis	0.000294	0.00151	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000294	0.00151	CcSEcCtD
Fexofenadine—Dry mouth—Estradiol—osteoporosis	0.000294	0.00151	CcSEcCtD
Fexofenadine—Asthenia—Pamidronate—osteoporosis	0.000294	0.00151	CcSEcCtD
Fexofenadine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000292	0.0015	CcSEcCtD
Fexofenadine—Pruritus—Pamidronate—osteoporosis	0.000289	0.00149	CcSEcCtD
Fexofenadine—Anaphylactic shock—Estradiol—osteoporosis	0.000288	0.00148	CcSEcCtD
Fexofenadine—Infection—Estradiol—osteoporosis	0.000286	0.00147	CcSEcCtD
Fexofenadine—Urticaria—Conjugated Estrogens—osteoporosis	0.000286	0.00147	CcSEcCtD
Fexofenadine—Dizziness—Risedronate—osteoporosis	0.000285	0.00146	CcSEcCtD
Fexofenadine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000284	0.00146	CcSEcCtD
Fexofenadine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000284	0.00146	CcSEcCtD
Fexofenadine—Tachycardia—Estradiol—osteoporosis	0.000281	0.00144	CcSEcCtD
Fexofenadine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000281	0.00144	CcSEcCtD
Fexofenadine—Diarrhoea—Pamidronate—osteoporosis	0.00028	0.00144	CcSEcCtD
Fexofenadine—Rash—Ethinyl Estradiol—osteoporosis	0.000278	0.00143	CcSEcCtD
Fexofenadine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000278	0.00143	CcSEcCtD
Fexofenadine—Headache—Ethinyl Estradiol—osteoporosis	0.000277	0.00142	CcSEcCtD
Fexofenadine—Hypersensitivity—Zoledronate—osteoporosis	0.000275	0.00142	CcSEcCtD
Fexofenadine—Vomiting—Risedronate—osteoporosis	0.000274	0.00141	CcSEcCtD
Fexofenadine—Rash—Risedronate—osteoporosis	0.000271	0.00139	CcSEcCtD
Fexofenadine—Dermatitis—Risedronate—osteoporosis	0.000271	0.00139	CcSEcCtD
Fexofenadine—Dizziness—Pamidronate—osteoporosis	0.000271	0.00139	CcSEcCtD
Fexofenadine—Headache—Risedronate—osteoporosis	0.00027	0.00139	CcSEcCtD
Fexofenadine—Asthenia—Zoledronate—osteoporosis	0.000268	0.00138	CcSEcCtD
Fexofenadine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000265	0.00136	CcSEcCtD
Fexofenadine—Pruritus—Zoledronate—osteoporosis	0.000264	0.00136	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000262	0.00135	CcSEcCtD
Fexofenadine—Nausea—Ethinyl Estradiol—osteoporosis	0.000262	0.00135	CcSEcCtD
Fexofenadine—Insomnia—Estradiol—osteoporosis	0.00026	0.00134	CcSEcCtD
Fexofenadine—Vomiting—Pamidronate—osteoporosis	0.00026	0.00134	CcSEcCtD
Fexofenadine—Asthenia—Conjugated Estrogens—osteoporosis	0.000258	0.00133	CcSEcCtD
Fexofenadine—Rash—Pamidronate—osteoporosis	0.000258	0.00133	CcSEcCtD
Fexofenadine—Dermatitis—Pamidronate—osteoporosis	0.000258	0.00132	CcSEcCtD
Fexofenadine—Dyspnoea—Estradiol—osteoporosis	0.000257	0.00132	CcSEcCtD
Fexofenadine—Headache—Pamidronate—osteoporosis	0.000256	0.00132	CcSEcCtD
Fexofenadine—Somnolence—Estradiol—osteoporosis	0.000256	0.00132	CcSEcCtD
Fexofenadine—Diarrhoea—Zoledronate—osteoporosis	0.000256	0.00131	CcSEcCtD
Fexofenadine—Nausea—Risedronate—osteoporosis	0.000256	0.00131	CcSEcCtD
Fexofenadine—Pruritus—Conjugated Estrogens—osteoporosis	0.000255	0.00131	CcSEcCtD
Fexofenadine—Dyspepsia—Estradiol—osteoporosis	0.000254	0.0013	CcSEcCtD
Fexofenadine—Fatigue—Estradiol—osteoporosis	0.000248	0.00128	CcSEcCtD
Fexofenadine—Dizziness—Zoledronate—osteoporosis	0.000247	0.00127	CcSEcCtD
Fexofenadine—Pain—Estradiol—osteoporosis	0.000246	0.00127	CcSEcCtD
Fexofenadine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000246	0.00127	CcSEcCtD
Fexofenadine—Nausea—Pamidronate—osteoporosis	0.000243	0.00125	CcSEcCtD
Fexofenadine—Dizziness—Conjugated Estrogens—osteoporosis	0.000238	0.00122	CcSEcCtD
Fexofenadine—Vomiting—Zoledronate—osteoporosis	0.000238	0.00122	CcSEcCtD
Fexofenadine—Rash—Zoledronate—osteoporosis	0.000236	0.00121	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Estradiol—osteoporosis	0.000236	0.00121	CcSEcCtD
Fexofenadine—Dermatitis—Zoledronate—osteoporosis	0.000235	0.00121	CcSEcCtD
Fexofenadine—Headache—Zoledronate—osteoporosis	0.000234	0.0012	CcSEcCtD
Fexofenadine—Vomiting—Conjugated Estrogens—osteoporosis	0.000229	0.00118	CcSEcCtD
Fexofenadine—Urticaria—Estradiol—osteoporosis	0.000229	0.00118	CcSEcCtD
Fexofenadine—Abdominal pain—Estradiol—osteoporosis	0.000228	0.00117	CcSEcCtD
Fexofenadine—Body temperature increased—Estradiol—osteoporosis	0.000228	0.00117	CcSEcCtD
Fexofenadine—Rash—Conjugated Estrogens—osteoporosis	0.000227	0.00117	CcSEcCtD
Fexofenadine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000227	0.00117	CcSEcCtD
Fexofenadine—Headache—Conjugated Estrogens—osteoporosis	0.000225	0.00116	CcSEcCtD
Fexofenadine—Nausea—Zoledronate—osteoporosis	0.000222	0.00114	CcSEcCtD
Fexofenadine—Nausea—Conjugated Estrogens—osteoporosis	0.000214	0.0011	CcSEcCtD
Fexofenadine—Hypersensitivity—Estradiol—osteoporosis	0.000212	0.00109	CcSEcCtD
Fexofenadine—Asthenia—Estradiol—osteoporosis	0.000207	0.00106	CcSEcCtD
Fexofenadine—Pruritus—Estradiol—osteoporosis	0.000204	0.00105	CcSEcCtD
Fexofenadine—Diarrhoea—Estradiol—osteoporosis	0.000197	0.00101	CcSEcCtD
Fexofenadine—Dizziness—Estradiol—osteoporosis	0.00019	0.000979	CcSEcCtD
Fexofenadine—Vomiting—Estradiol—osteoporosis	0.000183	0.000941	CcSEcCtD
Fexofenadine—Rash—Estradiol—osteoporosis	0.000182	0.000933	CcSEcCtD
Fexofenadine—Dermatitis—Estradiol—osteoporosis	0.000181	0.000932	CcSEcCtD
Fexofenadine—Headache—Estradiol—osteoporosis	0.00018	0.000927	CcSEcCtD
Fexofenadine—Nausea—Estradiol—osteoporosis	0.000171	0.000879	CcSEcCtD
Fexofenadine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	7.23e-05	0.00754	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MGLL—osteoporosis	7.14e-05	0.00746	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—ANXA2—osteoporosis	6.84e-05	0.00714	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	6.72e-05	0.00702	CbGpPWpGaD
Fexofenadine—HRH1—IL-4 Signaling Pathway—IRS2—osteoporosis	6.48e-05	0.00676	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	6.37e-05	0.00665	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.31e-05	0.00658	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.15e-05	0.00641	CbGpPWpGaD
Fexofenadine—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	6.08e-05	0.00635	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	5.75e-05	0.006	CbGpPWpGaD
Fexofenadine—HRH1—IL-4 Signaling Pathway—IRS1—osteoporosis	5.65e-05	0.0059	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	5.45e-05	0.00569	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—ANXA2—osteoporosis	5.34e-05	0.00558	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—PTH1R—osteoporosis	5.07e-05	0.00529	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—CALCR—osteoporosis	5.07e-05	0.00529	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.95e-05	0.00517	CbGpPWpGaD
Fexofenadine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	4.95e-05	0.00516	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.91e-05	0.00513	CbGpPWpGaD
Fexofenadine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	4.88e-05	0.0051	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.83e-05	0.00504	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.24e-05	0.00442	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—ANXA2—osteoporosis	4.2e-05	0.00438	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.18e-05	0.00436	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.13e-05	0.00431	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	4.05e-05	0.00423	CbGpPWpGaD
Fexofenadine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.01e-05	0.00419	CbGpPWpGaD
Fexofenadine—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	4e-05	0.00417	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	3.98e-05	0.00415	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.86e-05	0.00403	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PKM—osteoporosis	3.81e-05	0.00398	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—FDPS—osteoporosis	3.81e-05	0.00398	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PGLS—osteoporosis	3.61e-05	0.00377	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GPD2—osteoporosis	3.61e-05	0.00377	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.59e-05	0.00375	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	3.41e-05	0.00356	CbGpPWpGaD
Fexofenadine—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	3.4e-05	0.00355	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ATIC—osteoporosis	3.3e-05	0.00345	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PNP—osteoporosis	3.3e-05	0.00345	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.3e-05	0.00345	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.28e-05	0.00343	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	3.22e-05	0.00336	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PKM—osteoporosis	2.99e-05	0.00312	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—FDPS—osteoporosis	2.99e-05	0.00312	CbGpPWpGaD
Fexofenadine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.97e-05	0.0031	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PTH1R—osteoporosis	2.86e-05	0.00299	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CALCR—osteoporosis	2.86e-05	0.00299	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PGLS—osteoporosis	2.84e-05	0.00296	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GPD2—osteoporosis	2.84e-05	0.00296	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—OXCT1—osteoporosis	2.81e-05	0.00293	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CA2—osteoporosis	2.81e-05	0.00293	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.81e-05	0.00293	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—MGLL—osteoporosis	2.74e-05	0.00286	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—PTH—osteoporosis	2.66e-05	0.00278	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CALCR—osteoporosis	2.6e-05	0.00272	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PTH1R—osteoporosis	2.6e-05	0.00272	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—CNR2—osteoporosis	2.59e-05	0.00271	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PNP—osteoporosis	2.59e-05	0.00271	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ATIC—osteoporosis	2.59e-05	0.00271	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.58e-05	0.00269	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.57e-05	0.00268	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PKM—osteoporosis	2.56e-05	0.00267	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—FDPS—osteoporosis	2.56e-05	0.00267	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—WNT1—osteoporosis	2.44e-05	0.00255	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GPD2—osteoporosis	2.43e-05	0.00253	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PGLS—osteoporosis	2.43e-05	0.00253	CbGpPWpGaD
Fexofenadine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.41e-05	0.00252	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—IDH2—osteoporosis	2.33e-05	0.00243	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	2.29e-05	0.00239	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—MGLL—osteoporosis	2.28e-05	0.00238	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ATIC—osteoporosis	2.22e-05	0.00232	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PNP—osteoporosis	2.22e-05	0.00232	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—PTHLH—osteoporosis	2.21e-05	0.0023	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—OXCT1—osteoporosis	2.21e-05	0.0023	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CA2—osteoporosis	2.21e-05	0.0023	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CYP27A1—osteoporosis	2.19e-05	0.00228	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—MGLL—osteoporosis	2.15e-05	0.00224	CbGpPWpGaD
Fexofenadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	2.14e-05	0.00224	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	2.13e-05	0.00222	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ACP5—osteoporosis	2.13e-05	0.00222	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.1e-05	0.00219	CbGpPWpGaD
Fexofenadine—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	2.1e-05	0.00219	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MGLL—osteoporosis	2.07e-05	0.00216	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.03e-05	0.00212	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—ADCY5—osteoporosis	2e-05	0.00209	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—TPI1—osteoporosis	1.98e-05	0.00207	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—CALCA—osteoporosis	1.94e-05	0.00203	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CA2—osteoporosis	1.89e-05	0.00197	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—OXCT1—osteoporosis	1.89e-05	0.00197	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—IL1B—osteoporosis	1.88e-05	0.00196	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—P4HB—osteoporosis	1.86e-05	0.00194	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—MGLL—osteoporosis	1.84e-05	0.00192	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—IDH2—osteoporosis	1.83e-05	0.00191	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GAPDH—osteoporosis	1.83e-05	0.00191	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.8e-05	0.00188	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—RAP1A—osteoporosis	1.78e-05	0.00186	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	1.76e-05	0.00184	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.73e-05	0.00181	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CYP27A1—osteoporosis	1.72e-05	0.00179	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SOST—osteoporosis	1.7e-05	0.00177	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ACP5—osteoporosis	1.67e-05	0.00175	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.65e-05	0.00172	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.58e-05	0.00164	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—IDH2—osteoporosis	1.56e-05	0.00163	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—TPI1—osteoporosis	1.55e-05	0.00162	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.55e-05	0.00162	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CALCR—osteoporosis	1.54e-05	0.0016	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTH1R—osteoporosis	1.54e-05	0.0016	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PTH—osteoporosis	1.5e-05	0.00157	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CYP27A1—osteoporosis	1.47e-05	0.00153	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CNR2—osteoporosis	1.47e-05	0.00153	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—P4HB—osteoporosis	1.46e-05	0.00153	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—TGFB1—osteoporosis	1.46e-05	0.00152	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ENO1—osteoporosis	1.44e-05	0.0015	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GAPDH—osteoporosis	1.43e-05	0.0015	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ACP5—osteoporosis	1.43e-05	0.00149	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PSMA2—osteoporosis	1.42e-05	0.00148	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PSMA5—osteoporosis	1.42e-05	0.00148	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.41e-05	0.00147	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—RAP1A—osteoporosis	1.4e-05	0.00146	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.39e-05	0.00145	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PTH—osteoporosis	1.37e-05	0.00143	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—TNF—osteoporosis	1.36e-05	0.00142	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.35e-05	0.00141	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.33e-05	0.00139	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CNR2—osteoporosis	1.33e-05	0.00139	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—TPI1—osteoporosis	1.33e-05	0.00139	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—FDPS—osteoporosis	1.28e-05	0.00134	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PKM—osteoporosis	1.28e-05	0.00134	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—POMC—osteoporosis	1.28e-05	0.00134	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—WNT1—osteoporosis	1.25e-05	0.00131	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—P4HB—osteoporosis	1.25e-05	0.0013	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PTHLH—osteoporosis	1.25e-05	0.0013	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GAPDH—osteoporosis	1.23e-05	0.00128	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MGLL—osteoporosis	1.22e-05	0.00127	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.22e-05	0.00127	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PGLS—osteoporosis	1.21e-05	0.00127	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GPD2—osteoporosis	1.21e-05	0.00127	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—FDPS—osteoporosis	1.21e-05	0.00126	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PKM—osteoporosis	1.21e-05	0.00126	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.2e-05	0.00125	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—RAP1A—osteoporosis	1.19e-05	0.00125	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—LRP5—osteoporosis	1.19e-05	0.00124	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CYP19A1—osteoporosis	1.15e-05	0.0012	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PGLS—osteoporosis	1.14e-05	0.00119	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GPD2—osteoporosis	1.14e-05	0.00119	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—LRP6—osteoporosis	1.14e-05	0.00119	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PTHLH—osteoporosis	1.13e-05	0.00118	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ENO1—osteoporosis	1.13e-05	0.00118	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PSMA2—osteoporosis	1.11e-05	0.00116	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PSMA5—osteoporosis	1.11e-05	0.00116	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ATIC—osteoporosis	1.11e-05	0.00116	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PNP—osteoporosis	1.11e-05	0.00116	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CALCA—osteoporosis	1.1e-05	0.00115	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PNP—osteoporosis	1.05e-05	0.00109	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ATIC—osteoporosis	1.05e-05	0.00109	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.04e-05	0.00109	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—POMC—osteoporosis	1.02e-05	0.00106	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CALCA—osteoporosis	9.97e-06	0.00104	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ENO1—osteoporosis	9.66e-06	0.00101	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TLN1—osteoporosis	9.62e-06	0.001	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PSMA5—osteoporosis	9.52e-06	0.000994	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PSMA2—osteoporosis	9.52e-06	0.000994	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CA2—osteoporosis	9.45e-06	0.000986	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—OXCT1—osteoporosis	9.45e-06	0.000986	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ADCY5—osteoporosis	9.39e-06	0.00098	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GPX1—osteoporosis	9.36e-06	0.000977	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MGLL—osteoporosis	9.2e-06	0.000961	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CYP19A1—osteoporosis	9.03e-06	0.000943	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—OXCT1—osteoporosis	8.9e-06	0.000929	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CA2—osteoporosis	8.9e-06	0.000929	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MGLL—osteoporosis	8.67e-06	0.000905	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—MTHFR—osteoporosis	8.64e-06	0.000902	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—P4HB—osteoporosis	8.3e-06	0.000866	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTH—osteoporosis	8.07e-06	0.000843	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RAP1A—osteoporosis	7.93e-06	0.000828	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CNR2—osteoporosis	7.87e-06	0.000821	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	7.83e-06	0.000818	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—IDH2—osteoporosis	7.83e-06	0.000817	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—ADCY5—osteoporosis	7.81e-06	0.000815	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NFATC1—osteoporosis	7.74e-06	0.000808	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CYP19A1—osteoporosis	7.72e-06	0.000806	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—DKK1—osteoporosis	7.68e-06	0.000802	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—WNT1—osteoporosis	7.4e-06	0.000772	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ADCY5—osteoporosis	7.38e-06	0.00077	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—IDH2—osteoporosis	7.38e-06	0.00077	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP27A1—osteoporosis	7.36e-06	0.000768	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GPX1—osteoporosis	7.35e-06	0.000768	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	7.22e-06	0.000754	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	7.2e-06	0.000752	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGA—osteoporosis	7.2e-06	0.000751	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ACP5—osteoporosis	7.16e-06	0.000747	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—ADCY5—osteoporosis	7.09e-06	0.00074	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP27A1—osteoporosis	6.93e-06	0.000724	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—POMC—osteoporosis	6.91e-06	0.000721	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—MTHFR—osteoporosis	6.79e-06	0.000708	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ACP5—osteoporosis	6.75e-06	0.000704	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.74e-06	0.000704	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	6.73e-06	0.000702	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTHLH—osteoporosis	6.69e-06	0.000698	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—BMP2—osteoporosis	6.69e-06	0.000698	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—TPI1—osteoporosis	6.65e-06	0.000695	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGB—osteoporosis	6.55e-06	0.000683	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PSMA5—osteoporosis	6.32e-06	0.00066	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PSMA2—osteoporosis	6.32e-06	0.00066	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ADCY5—osteoporosis	6.31e-06	0.000659	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GPX1—osteoporosis	6.29e-06	0.000656	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—TPI1—osteoporosis	6.27e-06	0.000655	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—P4HB—osteoporosis	6.26e-06	0.000653	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GAPDH—osteoporosis	6.14e-06	0.000641	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—RAP1A—osteoporosis	5.98e-06	0.000624	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—P4HB—osteoporosis	5.9e-06	0.000616	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CALCA—osteoporosis	5.89e-06	0.000615	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—MTHFR—osteoporosis	5.8e-06	0.000606	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GAPDH—osteoporosis	5.79e-06	0.000604	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—POMC—osteoporosis	5.74e-06	0.0006	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—RAP1A—osteoporosis	5.64e-06	0.000588	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—POMC—osteoporosis	5.43e-06	0.000566	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KL—osteoporosis	5.35e-06	0.000558	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—POMC—osteoporosis	5.22e-06	0.000544	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6R—osteoporosis	5.09e-06	0.000531	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ENO1—osteoporosis	4.84e-06	0.000505	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PSMA2—osteoporosis	4.76e-06	0.000497	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PSMA5—osteoporosis	4.76e-06	0.000497	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—POMC—osteoporosis	4.64e-06	0.000484	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ENO1—osteoporosis	4.56e-06	0.000476	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PSMA2—osteoporosis	4.49e-06	0.000469	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PSMA5—osteoporosis	4.49e-06	0.000469	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ADCY5—osteoporosis	4.19e-06	0.000437	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SPP1—osteoporosis	4.05e-06	0.000423	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP19A1—osteoporosis	3.87e-06	0.000404	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IRS2—osteoporosis	3.67e-06	0.000383	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP19A1—osteoporosis	3.64e-06	0.00038	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—LEP—osteoporosis	3.59e-06	0.000374	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ESR1—osteoporosis	3.42e-06	0.000357	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IRS1—osteoporosis	3.2e-06	0.000334	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ADCY5—osteoporosis	3.16e-06	0.00033	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GPX1—osteoporosis	3.15e-06	0.000329	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—POMC—osteoporosis	3.08e-06	0.000322	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6R—osteoporosis	3.01e-06	0.000314	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ADCY5—osteoporosis	2.98e-06	0.000311	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GPX1—osteoporosis	2.97e-06	0.00031	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IGF1—osteoporosis	2.96e-06	0.000309	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MTHFR—osteoporosis	2.9e-06	0.000303	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MTHFR—osteoporosis	2.74e-06	0.000286	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—POMC—osteoporosis	2.32e-06	0.000243	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6—osteoporosis	2.27e-06	0.000237	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—POMC—osteoporosis	2.19e-06	0.000229	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MYC—osteoporosis	1.78e-06	0.000186	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TGFB1—osteoporosis	1.78e-06	0.000185	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6—osteoporosis	1.34e-06	0.00014	CbGpPWpGaD
